The latest issue of Leading Discoveries highlights research-driven progress in cancer science and medicine.
Read Leading Discoveries
Cancer is not a single disease, but rather a collection of diseases all characterized by the uncontrolled proliferation of cells.
Learn MoreDisparities in Cancer Screening: Racial and ethnic minority populations and medically underserved communities experience substantial disparities in receiving the recommended cancer screenings.
Read the ReportAlthough it is relatively rare, male breast cancer will be diagnosed in an estimated 2,800 people in the United States this year. October is Breast Cancer Awareness Month.
Learn MoreCould binge drinking be contributing to the rise of breast cancer in women under 40? Researchers are examining the potential link between higher rates of binge drinking and early-onset cancers.
Learn More on the AACR BlogInvesting in Innovation: The AACR grants program sparks innovation in basic, translational, and clinical research by providing critical support to promising investigators at all career levels.
Read MoreWhether honoring a special person or a special day, a donation to the American Association for Cancer Research has a lasting impact.
Donate NowThe Call for Abstracts for the AACR Annual Meeting 2027 (April 2-7) is now available. Abstract Deadline: November 10
The AACR Cancer Progress Report 2026 highlights the remarkable progress against cancers driven by discoveries across basic, translational, clinical, and population science.
Learn MoreThe AACR and its more than 65,000 members worldwide are advancing a scientifically bold agenda against the collection of diseases we call cancer.
Learn MoreThe AACR Cancer Disparities Progress Report 2026 provides a comprehensive overview of the latest research on cancer disparities and calls for policies to reduce disparities and achieve cancer health equity.
Learn Morepercent decrease of the overall age-adjusted cancer death rate in the U.S. from 1991 to 2024
Learn Moretherapeutics were approved for new or expanded uses by the FDA from July 1, 2025, to June 30, 2026
Learn Moremillion cancer survivors in the U.S. are living with, through, and beyond their disease thanks to research
Learn More